Efficacy and safety of dupilumab in patients with uncontrolled severe CRSwNP and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trials Article

Industry Collaboration International Collaboration

author list

  • Mullol, Joaquim; Laidlaw, Tanya M.; Bachert, Claus; Mannent, Leda P.; Canonica, G. Walter; Han, Joseph K.; Maspero, Jorge F.; Picado, Cesar; Daizadeh, Nadia; Ortiz, Benjamin; Li, Yongtao; Ruddy, Marcella; Laws, Elizabeth; Amin, Nikhil

publication date

  • October 1, 2021


published in



  • IL-13
  • IL-4
  • chronic rhinosinusitis with nasal polyps
  • dupilumab
  • non-steroidal anti-inflammatory drug-exacerbated respiratory disease